# Bromocriptine

## Volbro 2.5mg

| 藥物代碼 | OPARL |
| :--- | :--- |
| 適應症 | Galactorrhea &/or prolactin-dependent amenorrhea, female infertility, Suppression of lactation, Pre-menstrual syndrome, Male hypogonadism, Acromegaly, Parkinson's disease. |
| 副作用 | Slight nausea, dizziness, fatigue, vomiting, orthostatic hypotension, constipation, drowsiness.Cardiovascular: Hypotension \(type 2 diabetes, 2.2% \)Gastrointestinal: Constipation \(acromegaly, 14%; hyperprolactinemic indications, 3%; type 2 diabetes, 5.8% to 11.3% \), Diarrhea \(hyperprolactinemic indications, 3%; type 2 diabetes, 8.1% to 8.8% \), Indigestion \(acromegaly, 4%; type 2 diabetes, 7.5% \), Nausea \(acromegaly, 18%; hyperprolactinemic indications, 49%; type 2 diabetes, 25.4% to 32.5% \), Vomiting \(acromegaly, 2%; hyperprolactinemic indications, 5%; type 2 diabetes, 5.3% to 8.1% \)Neurologic: Asthenia \(type 2 diabetes, 12.5% to 18.9% \), Dizziness \(hyperprolactinemic indications, 17%; type 2 diabetes, 11.9% to 14.8% \), Headache \(hyperprolactinemic indications, 19%; type 2 diabetes, 11.4% to 16.8% \), Somnolence \( 3% to 6.6% \)Ophthalmic: Amblyopia \(type 2 diabetes, 5.3% to 7.5% \)Respiratory: Rhinitis \(type 2 diabetes 10.7% to 13.8% \), Sinusitis \(type 2 diabetes, 7.4% to 10% \)Other: Fatigue \(hyperprolactinemia indications, 7%; type 2 diabetes, 13.9% \) |
| 禁忌 | Hypersensitivity to bromocriptine or ergot alkaloids, uncontrolled hypertension during pregnancy, post-partum or puerperal period. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Inhibition of lactation: 2.5 mg bid for 14 days to max. of 21 days. Amenorrhea/galactorrhea: 2.5 mg bid-tid. Parkinsonian disease: 1.25 mg bid, may be increased every 14-28 days by 2.5 mg/day. Infertility: 2.5 mg/day, increased within 1 week to 2.5 mg bid-tid. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

